Quantitative real-time-PCR and immunoblotting analyses of postmortem AD brains and APP transgenic mice revealed significantly increased VDAC1 mRNA and protein levels, correlating with disease progression and age [41]. This evidence concerns the gene VDAC1 and Alzheimer disease.